Clinical trial
AZD5438 in Patients With Advanced Solid Malignancies
NCT00088790 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00088790 |
|---|---|
| Title | AZD5438 in Patients With Advanced Solid Malignancies |
| Official title | Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients With Advanced Solid Malignancies |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | AZD5438 |
| Start date | Jul 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Aug 5, 2004 |
| Last update posted | Jan 26, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: